Cargando…
Alzheimer’s disease – the journey of a healthy brain into organ failure
As the most common dementia, Alzheimer’s disease (AD) exacts an immense personal, societal, and economic toll. AD was first described at the neuropathological level in the early 1900s. Today, we have mechanistic insight into select aspects of AD pathogenesis and have the ability to clinically detect...
Autor principal: | Golde, Todd E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898417/ https://www.ncbi.nlm.nih.gov/pubmed/35248124 http://dx.doi.org/10.1186/s13024-022-00523-1 |
Ejemplares similares
-
Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases
por: Golde, Todd E, et al.
Publicado: (2009) -
Open questions for Alzheimer’s disease immunotherapy
por: Golde, Todd E
Publicado: (2014) -
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
por: Golde, Todd E.
Publicado: (2022) -
Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
por: Golde, Todd E, et al.
Publicado: (2013) -
Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
por: Galasko, Douglas, et al.
Publicado: (2013)